Soc. Generale Call 3050 AZO 17.01.../ DE000SV7HVX0 /
27/06/2024 09:34:15 | Var.-0.08 | Denaro14:02:59 | Lettera14:02:59 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.86EUR | -4.12% | 1.85 Quantità in denaro: 2,000 |
2.15 Quantità in lettera: 2,000 |
AutoZone Inc | 3,050.00 - | 17/01/2025 | Call |
GlobeNewswire
14:18
Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights
GlobeNewswire
14:15
The Chainsmokers and Bebe Rexha Headline The Challenge, Abercrombie & Fitch Co.’s Annual Festival an...
GlobeNewswire
14:13
Xylo Technologies: Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems...
GlobeNewswire
14:12
Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems in Automatic Car P...
GlobeNewswire
14:07
Global Study Finds Only 22% Effectively Using Gen AI Across All Business Functions
GlobeNewswire
14:05
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
GlobeNewswire
14:04
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
GlobeNewswire
14:03
American Rare Earths to Receive A$10.7 Million (US$7.1 Million) of Grant Funding from State of Wyomi...
GlobeNewswire
14:02
Dawn Bates, Founder of Dawn Bates International Reaches the Finals for the Social Impact Award in Na...
GlobeNewswire
14:01
Redwood Feeds Snak-King’s Appetite for Transportation Innovation Amid Supply Chain Disruption
GlobeNewswire
14:00
HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities
GlobeNewswire
14:00
As Consumers’ Monthly Debt Loads Increase, Auto Lenders Must Adapt to Manage Risk, Increase Originat...
GlobeNewswire
14:00
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial
GlobeNewswire
14:00
Kaspi.kz to Announce 2nd Quarter and 1st Half 2024 Financial Results on 22nd July
GlobeNewswire
14:00
TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale